ID

22190

Descrizione

Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00112346

collegamento

https://clinicaltrials.gov/show/NCT00112346

Keywords

versioni (1)
  1. 22/05/17 22/05/17 -
Caricato su

22 maggio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Non-Small-Cell Lung Carcinoma NCT00112346

Inglese

Eligibility Non-Small-Cell Lung Carcinoma NCT00112346

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have advanced or metastatic non-small cell lung cancer that has not been previously treated with any chemotherapy.
Descrizione

Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer metastatic | Prior Chemotherapy Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278987
UMLS CUI [3,1]
C1514457
UMLS CUI [3,2]
C0332197
must not have received cetuximab or any medications that target the same pathway as cetuximab (such as iressa or tarceva).
Descrizione

Cetuximab Absent | Iressa Absent | Tarceva Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0995188
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0919281
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1135136
UMLS CUI [3,2]
C0332197
must not have had hypersensitivity or severe allergic reactions to any monoclonal antibodies and must not have severe restrictive or interstitial lung disease.
Descrizione

Monoclonal Antibodies Hypersensitivity Absent | Monoclonal Antibodies Allergic Reaction Severe Absent | Restrictive lung disease Severe Absent | Interstitial Lung Diseases Severe Absent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003250
UMLS CUI [1,2]
C0020517
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0003250
UMLS CUI [2,2]
C1527304
UMLS CUI [2,3]
C0205082
UMLS CUI [2,4]
C0332197
UMLS CUI [3,1]
C0085581
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0206062
UMLS CUI [4,2]
C0205082
UMLS CUI [4,3]
C0332197
must be able to carry out work of light or sedentary nature (e.g. light house work, office work).
Descrizione

Light Work Perform Able | Light work around the house Perform Able | Work Sedentary Perform Ability

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2987220
UMLS CUI [1,2]
C0884358
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C3842657
UMLS CUI [2,2]
C0884358
UMLS CUI [2,3]
C0085732
UMLS CUI [3,1]
C0043227
UMLS CUI [3,2]
C0205254
UMLS CUI [3,3]
C0884358
UMLS CUI [3,4]
C0085732
it must be at least 4 weeks since last major surgery or prior treatment with an investigational product and at least 12 weeks from any radiation therapy to the chest.
Descrizione

major surgery | Investigational New Drugs | Therapeutic radiology procedure Chest

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C0013230
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0817096
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
women who are pregnant or breastfeeding.
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
women with a positive pregnancy test on enrollment or prior to study drug administration.
Descrizione

Gender Pregnancy test positive

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0240802
any concurrent malignancy (subjects with a previous malignancy but without evidence of disease for 5 years will be allowed to enter the trial).
Descrizione

Malignant Neoplasms | Malignant Neoplasm Previous Disease Free of

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0205156
UMLS CUI [2,3]
C0012634
UMLS CUI [2,4]
C0332296
symptomatic or uncontrolled metastases in the central nervous system (cns).
Descrizione

CNS metastases Symptomatic | CNS metastases Uncontrolled

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C0686377
UMLS CUI [2,2]
C0205318
peripheral neuropathy.
Descrizione

Peripheral Neuropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0031117
inadequate hematologic function defined by an absolute neutrophil count (anc) <1,500/mm^3, a platelet count <100,000/mm^3, or a hemoglobin level < 9g/dl.
Descrizione

Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0221130
UMLS CUI [1,2]
C0205412
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
inadequate liver function.
Descrizione

Liver Dysfunction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0086565
inadequate kidney function.
Descrizione

Abnormal renal function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151746
Ritorna all'inizio della pagina

Similar models

Eligibility Non-Small-Cell Lung Carcinoma NCT00112346

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced | Non-small cell lung cancer metastatic | Prior Chemotherapy Absent
Item
must have advanced or metastatic non-small cell lung cancer that has not been previously treated with any chemotherapy.
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278987 (UMLS CUI [2])
C1514457 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Cetuximab Absent | Iressa Absent | Tarceva Absent
Item
must not have received cetuximab or any medications that target the same pathway as cetuximab (such as iressa or tarceva).
boolean
C0995188 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0919281 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1135136 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Monoclonal Antibodies Hypersensitivity Absent | Monoclonal Antibodies Allergic Reaction Severe Absent | Restrictive lung disease Severe Absent | Interstitial Lung Diseases Severe Absent
Item
must not have had hypersensitivity or severe allergic reactions to any monoclonal antibodies and must not have severe restrictive or interstitial lung disease.
boolean
C0003250 (UMLS CUI [1,1])
C0020517 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0003250 (UMLS CUI [2,1])
C1527304 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
C0085581 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0206062 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
Light Work Perform Able | Light work around the house Perform Able | Work Sedentary Perform Ability
Item
must be able to carry out work of light or sedentary nature (e.g. light house work, office work).
boolean
C2987220 (UMLS CUI [1,1])
C0884358 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C3842657 (UMLS CUI [2,1])
C0884358 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
C0043227 (UMLS CUI [3,1])
C0205254 (UMLS CUI [3,2])
C0884358 (UMLS CUI [3,3])
C0085732 (UMLS CUI [3,4])
major surgery | Investigational New Drugs | Therapeutic radiology procedure Chest
Item
it must be at least 4 weeks since last major surgery or prior treatment with an investigational product and at least 12 weeks from any radiation therapy to the chest.
boolean
C0679637 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C1522449 (UMLS CUI [3,1])
C0817096 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Gender Pregnancy test positive
Item
women with a positive pregnancy test on enrollment or prior to study drug administration.
boolean
C0079399 (UMLS CUI [1,1])
C0240802 (UMLS CUI [1,2])
Malignant Neoplasms | Malignant Neoplasm Previous Disease Free of
Item
any concurrent malignancy (subjects with a previous malignancy but without evidence of disease for 5 years will be allowed to enter the trial).
boolean
C0006826 (UMLS CUI [1])
C0006826 (UMLS CUI [2,1])
C0205156 (UMLS CUI [2,2])
C0012634 (UMLS CUI [2,3])
C0332296 (UMLS CUI [2,4])
CNS metastases Symptomatic | CNS metastases Uncontrolled
Item
symptomatic or uncontrolled metastases in the central nervous system (cns).
boolean
C0686377 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0686377 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Peripheral Neuropathy
Item
peripheral neuropathy.
boolean
C0031117 (UMLS CUI [1])
Hematologic function Inadequate | Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
inadequate hematologic function defined by an absolute neutrophil count (anc) <1,500/mm^3, a platelet count <100,000/mm^3, or a hemoglobin level < 9g/dl.
boolean
C0221130 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Liver Dysfunction
Item
inadequate liver function.
boolean
C0086565 (UMLS CUI [1])
Abnormal renal function
Item
inadequate kidney function.
boolean
C0151746 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial